MACROGENICS INC — Director's Dealing 2018

Feb 12, 2018

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2017-12-31

Reporting Person: Peters Jeffrey Stuart (Acting General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-31	Common Stock	A	270	$15.05	Acquired	270	Direct

Footnotes

F1: The reporting person is voluntarily reporting the acquisition of the issuer's common stock pursuant to the MacroGenics, Inc. Employee Stock Purchase Plan. This acquisition was exempt under both Rule 16b-3(d) and Rule 16b-3(c).